News
Essai clinique REGO-INTER-EWING
Essai clinique REGO-INTER-EWING
IMPROVING THE PROGNOSIS OF CHILDREN WITH EWING SARCOMA This trial on Ewing sarcoma was co-funded by the Enfants sans Cancer 2021 race and was selected as part of our European Fight Kids Cancer grant call. About Ewing Sarcoma Ewing sarcoma is the second most common malignant bone tumor after osteosarcoma among adolescents […]GLO-BNHL
GLO-BNHL
A UNIQUE INTERNATIONAL PLATEFORM OF CLINICAL TRIALS ON PEDIATRIC LYMPHOMAS This trial on relapsed and refractory pediatric B-cell non-Hodgkin lymphomas (BNHL) was co-funded by the Enfants sans Cancer 2021 race and was selected as part of our European Fight Kids Cancer grant call. About Lymphomas Pediatric non-Hodgkin lymphoma (NHL) is a cancer that originates […]COMBALK
COMBALK
This trial on pediatric neuroblastomas was co-funded by the Enfants sans Cancer 2021 race and was selected as part of our European Fight Kids Cancer grant call. About Neuroblastomas in Children Neuroblastoma is an extracranial malignant tumor that develops from primitive nerve cells called neuroblasts, which normally form nerve cells in the body. This […]CARBEMED
CARBEMED
This trial on medulloblastomas was co-funded by the Enfants sans Cancer 2021 race and was selected as part of our European Fight Kids Cancer grant call. About Medulloblastomas in Children Medulloblastoma is the most common embryonal tumor of the central nervous system. This pathology develops in the cerebellum, which is important for motor control, […]BEACON BIO
BEACON BIO
This trial on neuroblastomas was co-funded by the Enfants sans Cancer 2021 race and was selected as part of our European Fight Kids Cancer grant call. About Neuroblastomas A neuroblastoma is a malignant extracerebral tumor that develops from primitive nerve cells called neuroblasts, which normally form the body’s nerve cells. This type of solid […]Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas
Molecular Analysis and Testing of New Treatments for Diffuse Midline Gliomas
Diffuse Midline Gliomas in Children Pediatric brain tumors are the leading cause of cancer-related mortality in children. Diffuse midline gliomas are the most common and severe form of malignant gliomas in children and adolescents (between 50 and 100 new cases are expected each year in France). Most affected children die within two years of diagnosis. […]SACHA : le programme qui sécurise l’accès aux médicaments en dehors des essais cliniques
